Premium Nahrungsergänzungsmittel | artgerecht

Trigeminal Neuralgia – Causes, Symptoms & Treatment

Trigeminal neuralgia is a severe, episodic facial pain disorder affecting the trigeminal nerve. The sudden, electric shock-like pain attacks are considered one of the most intense pain conditions known in medicine.

Regular tips about health Regular tips about health

Things worth knowing about "Trigeminal Neuralgia"

Trigeminal neuralgia is a severe, episodic facial pain disorder affecting the trigeminal nerve. The sudden, electric shock-like pain attacks are considered one of the most intense pain conditions known in medicine.

What is Trigeminal Neuralgia?

Trigeminal neuralgia is a chronic pain condition affecting the trigeminal nerve – the fifth cranial nerve responsible for sensation in the face. The condition is characterized by sudden, extremely intense, stabbing or electric shock-like episodes of facial pain. It is widely regarded as one of the most painful conditions a person can experience. The disorder affects women more often than men and typically occurs in people over the age of 50.

Causes

In most cases, trigeminal neuralgia is caused by compression of the trigeminal nerve at its entry point into the brainstem. A blood vessel – usually an artery – presses against the nerve and damages its protective myelin sheath, disrupting normal nerve function. Other possible causes include:

Multiple sclerosis: Demyelination of the nerve can trigger abnormal pain signals.
Tumors: Rarely, a tumor near the trigeminal nerve can exert pressure on it.
Arteriovenous malformations: Abnormal blood vessel formations can compress the nerve.
Idiopathic forms: In some cases, no clear cause can be identified.

Symptoms

The hallmark symptom of trigeminal neuralgia is sudden, one-sided facial pain with the following typical characteristics:

Abrupt onset of stabbing or electric shock-like pain lasting seconds to a few minutes
Pain typically in the distribution areas of the second (cheek, upper lip, upper teeth) and/or third branch of the trigeminal nerve (lower jaw, lower lip, tongue)
Attacks triggered by light touch, talking, chewing, brushing teeth, or a gust of wind – known as trigger points
Pain-free intervals between attacks, especially early in the course of the disease
In advanced stages, persistent background pain may develop

Diagnosis

The diagnosis of trigeminal neuralgia is primarily based on a clinical evaluation and the detailed description of symptoms provided by the patient. Additional diagnostic steps include:

MRI (Magnetic Resonance Imaging): To visualize the brainstem and identify vascular compression, tumors, or signs of multiple sclerosis
Neurological examination: Assessment of facial sensation and motor function
Differential diagnosis: Dental conditions, temporomandibular joint disorders, and other facial pain syndromes must be ruled out

Treatment

Medication-Based Therapy

Drug therapy is typically the first line of treatment. The primary medication of choice is:

Carbamazepine: An anticonvulsant that reduces nerve excitability and is effective for most patients. Dosage is individually adjusted.
Oxcarbazepine: An alternative with a similar mechanism of action and often a better tolerability profile
Gabapentin, Pregabalin, Lamotrigine: Additional options when first-line therapy is insufficient or poorly tolerated

Interventional and Surgical Therapy

When medications are not effective enough or are not well tolerated, several interventional and surgical options are available:

Microvascular decompression (MVD): A neurosurgical procedure in which the compressing blood vessel is separated from the nerve and a protective cushion is placed between them. It is considered the most effective long-term treatment.
Stereotactic radiosurgery (Gamma Knife): Precisely targeted radiation of the trigeminal nerve root, a non-invasive outpatient procedure
Percutaneous procedures: Such as thermocoagulation, glycerol rhizolysis, or balloon compression at the Gasserian ganglion – minimally invasive techniques to interrupt pain transmission

References

Cruccu G et al. EAN guidelines on trigeminal neuralgia. European Journal of Neurology. 2016;23(10):1153-1162. DOI: 10.1111/ene.13085
Zakrzewska JM, Linskey ME. Trigeminal neuralgia. BMJ. 2014;348:g474. DOI: 10.1136/bmj.g474
National Institute of Neurological Disorders and Stroke (NINDS). Trigeminal Neuralgia Fact Sheet (2023). Available at: https://www.ninds.nih.gov

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.